Neurocrine Biosciences, Inc. Apr 1, 2022 at 4:00 AM UTC OriginalELI5 Neurocrine Biosciences Presents Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease at AAN 2022 - Valbenazine Met the Primary Endpoint of Significant (p
